Details for 2016750567
Up to date per 02.04.2026
Actions
Details for 2016750567
Granted/Registered
European Patent
06.06.2018 A
07.10.2020 B1
31.07.2015
US
201562199563 P
27.01.2016
US
201662287518 P
C12N 15/113 20100101AFI20170215BHEP
Owner
Alnylam Pharmaceuticals, Inc.300 Third Street, 3rd Floor Cambridge, MA 02142US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
ZIMMERMANN, Tracy300 Third Street 3rd Floor Cambridge, MA 02142US
CHAN, Amy300 Third Street 3rd Floor Cambridge, MA 02142US
JADHAV, Vasant300 Third Street 3rd Floor Cambridge, MA 02142US
MAIER, Martin300 Third Street 3rd Floor Cambridge, MA 02142US
RAJEEV, Kallanthottathil, G.300 Third Street 3rd Floor Cambridge, MA 02142US
Information about Fees